[SCHEDULE 13G/A] Imunon, Inc. SEC Filing

Rhea-AI Filing Summary

Reporting persons Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC disclose beneficial ownership in Imunon, Inc. The filing shows each may be deemed to beneficially own 1,067,196 shares of common stock, representing 4.99% of the class. That figure is calculated using the issuer's reported outstanding shares of 20,319,511 plus 1,067,196 shares issuable upon exercise of an Intracoastal warrant.

The report states sole voting and dispositive power are 0 and shared voting and dispositive power are 1,067,196. It also discloses an additional 1,155,028 warrant shares are excluded because the warrant is not currently exercisable pending stockholder approval and includes a blocker limiting exercise above 4.99%. Without that blocker and if currently exercisable, the filing notes each reporting person could be deemed to own 2,222,224 shares.

Positive

• Clear disclosure of beneficial ownership: 1,067,196 shares (4.99%) reported for each reporting person
• Transparency around warrant mechanics and an explicit blocker provision that limits immediate exercise above 4.99%
• Shared voting and dispositive power disclosed (1,067,196), with 0 sole voting/dispositive power, reducing unilateral control risk

Negative

• Reporting persons hold concentrated shared voting/dispositive power of 1,067,196 shares, which could matter to some investors
• Warrants could increase potential ownership to 2,222,224 shares per reporting person if exercisable without the blocker, indicating possible future dilution or concentration

Insights

Financial Analyst

TL;DR: Beneficial ownership is disclosed at 4.99%, below the 5% reporting threshold, with warrants and a blocker that limit immediate control.

The filing provides clear, quantified disclosure: 1,067,196 shares equate to 4.99% of the common stock on the stated basis of 20,319,511 outstanding shares plus the warrant shares. Voting and dispositive power are shared, not sole, which reduces immediate unilateral control risk. Materiality is limited because the position is under 5% and the holder has no sole voting authority, though warrant mechanics could change future ownership math if exercisable or if shareholder approval is obtained.

Corporate Governance Expert

TL;DR: This is a routine Schedule 13G disclosure showing a sub-5% stake with a blocker and non‑exercisable warrant that constrain escalation of voting influence.

The report identifies the reporting group and discloses both the actual beneficial ownership used for the percentage calculation and the excluded warrant shares (1,155,028) that are not exercisable until stockholder approval. The presence of a blocker provision explicitly prevents exercise that would push ownership above 4.99%, which is important for governance and control considerations. Overall, the filing increases transparency but does not signal a change of control.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Imunon, Inc.

(Name of Issuer)

Common stock, par value $0.01 per share

(Title of Class of Securities)

15117N602

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 15117N602

1

Names of Reporting Persons

Mitchell P. Kopin

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,067,196.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,067,196.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,067,196.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP No. 15117N602

1

Names of Reporting Persons

Daniel B. Asher

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,067,196.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,067,196.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,067,196.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP No. 15117N602

1

Names of Reporting Persons

Intracoastal Capital LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,067,196.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,067,196.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,067,196.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.99 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Imunon, Inc.
(b)	Address of issuer's principal executive offices: 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648-2311
Item 2.
(a)	Name of person filing: This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons").
(b)	Address or principal business office or, if none, residence: The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 1011 Lake Street, Suite 311, Oak Park, Illinois 60301.
(c)	Citizenship: Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company.
(d)	Title of class of securities: Common stock, par value $0.01 per share
(e)	CUSIP No.: 15117N602
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: As of the close of business on June 30, 2025, each of the Reporting Persons may have been deemed to have beneficial ownership of 1,067,196 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal ("Intracoastal Warrant 1"), and all such shares of Common Stock represent beneficial ownership of approximately 4.99% of the Common Stock, based on (1) 20,319,511 shares of Common Stock outstanding on May 28, 2025, as reported by the Issuer, plus (2) 1,067,196 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1. The foregoing excludes 1,155,028 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal ("Intracoastal Warrant 1") because Intracoastal Warrant 1 is not exercisable until the effective date of stockholder approval of the issuance of the shares of Common Stock issuable upon exercise of Intracoastal Warrant 1 (and Intracoastal Warrant 1 also contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 1 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock). Without such blocker provision (and assuming Intracoastal 1 was currently exercisable), each of the Reporting Persons may have been deemed to have beneficial ownership of 2,222,224 shares of Common Stock.
(b)	Percent of class: 4.99%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 1,067,196
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 1,067,196
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Mitchell P. Kopin

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin
Date:	08/12/2025

Daniel B. Asher

Signature:	/s/ Daniel B. Asher
Name/Title:	Daniel B. Asher
Date:	08/12/2025

Intracoastal Capital LLC

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin, Manager
Date:	08/12/2025

FAQ

How many Imunon (IMNN) shares do the reporting persons disclose owning?

The filing shows beneficial ownership of 1,067,196 shares for each reporting person, representing 4.99% of the class on the stated basis.

Who filed the Schedule 13G/A for IMNN?

The filing was made on behalf of Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC.

What voting and dispositive power do the reporting persons have?

Sole voting and dispositive power are reported as 0; shared voting and shared dispositive power are reported as 1,067,196 shares.

Are there warrants related to the disclosed position in IMNN?

Yes. The calculation includes 1,067,196 shares issuable upon exercise of an Intracoastal warrant; an additional 1,155,028 warrant shares are excluded because the warrant is not currently exercisable pending stockholder approval.

Could the reporting persons' ownership exceed 5%?

The filing states a blocker provision prevents exercise to the extent it would result in beneficial ownership above 4.99%; without that blocker and if exercisable, each could be deemed to own 2,222,224 shares.